
Last updated: 2026-10-08 00:34:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GlucoTrack, Inc. (GCTK) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.14, with a market capitalization of $1.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.07 to $136.29. This page covers its latest market performance, valuation, price trends and company information.
$1.13M | |
$1.12 | |
$381,600.00 | |
$1.07 | |
$1.13 | |
92.77K | |
2.09M | |
-- | |
$136.29 | |
$1.07 | |
-- | |
-- |
GlucoTrack, Inc. (GCTK) last closed at $1.13 as of 2026-10-07 23:47:00, unchanged from the previous close of $1.13.
During the latest regular trading session, GCTK traded between $1.07 and $381,600.00, with a volume of 92.77K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, GlucoTrack, Inc. (GCTK) moved from $1.80 to $1.14, representing a decline of 36.61% ($0.66).
The stock traded between $1.07 and $1.95 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 474.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.1%
GCTK is currently trading at $1.14, placing it 0.1% of the way from its 52-week low of $1.07 to its 52-week high of $136.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 15 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GlucoTrack, Inc. (GCTK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.